Abstract 2139P
Background
Long-term cancer survivors (LS), patients over 5 years free of disease, are a population on the rise due to oncological advances. Our aim is to explore QLACS in long-term cancer survival patients in Spain. As a secondary objective is to study their clinical and sociodemographic characteristics and their preference for social media or face-to-face meetings to obtain oncological information.
Methods
We carried out a transversal study in a sample of LS patients from several Spanish hospitals. They completed QLACS, FERREL, SPF12 and social media data. Different types of tumor were included. Psychometric properties of the QLACS were evaluated. Principal component analysis with Varimax rotation was applied to explore the dimensional structure. Pearson’s correlation (Pc) was used to study associations of QLACS with temporal variables. Student’s t test was used to study differences between them.
Results
N= 257, women=59,9 %, < 65 years=55%. Types Tumor: 33% breast, 27% colorectal, 8,9% urothelial, 7,4% other digestive tumors, 7% orl-lung. Factor analysis showed a 12-component solution accounts for 71.03 % of the variance, showing a similar comparable dimensional structure with QLACS. Alfa Cronbach=0,9. Appearance concern, distress over recurrence, pain, negative feelings and distress familiar are statistically higher in female (p<0,05). We found negative correlation between age and use of social networks for oncological information (Facebook: p = 0.01, Pc: -248; Twitter: p<0.04, Pc:- 200; Instagram: p <0.007, Pc: -259 except; Youtube: p = 0.17; Pc: -134). No differences by sex were observed in the use of social networks There were no differences by age in attending face-to-face meetings: p< 0.94, Pc: - 196. Breast cancer patients are more willing to attend face-to-face meetings to help other patients than those with colon cancer (p< 0.036).
Conclusions
QLACS is a valid and reliable instrument for measuring quality of life in long-term cancer survivors in Spain. Younger patients are more likely to use social media for oncology information. Older people tend to prefer face-to-face meetings. We found differences between men and women in different factors for measuring quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
M. Cornide.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2162P - Can artificial intelligence provide accurate and reliable answers to cancer patients' questions? Comparison of chatbots based on the ESMO Patient Guide about cancer pain
Presenter: Kadriye Bir Yucel
Session: Poster session 07
2163P - Supportive care in French community pharmacies: OncoPharma certification
Presenter: Jérôme Sicard
Session: Poster session 07
2164P - The impact of cancer patients’ face masks on oxygenation and Co2 retention during treatment
Presenter: Mert Sahin
Session: Poster session 07
2165P - A French overview of electronic patient-reported outcomes use in 2022
Presenter: Melina Hocine
Session: Poster session 07
2166P - Long-term consequences of SARS-CoV-2 infection in cancer patients
Presenter: Yana Debie
Session: Poster session 07
2167P - Are bone targeted agents (BTAs) still useful in times of immunotherapy? The SAKK 80/19 BTA study
Presenter: Michael Mark
Session: Poster session 07
2168P - At-home infusion of immunotherapy for patients with solid tumors: First results from a single-centre program
Presenter: Javier Marco Hernández
Session: Poster session 07
2169P - Immunotherapy-based treatment in elderly cancer patients: A real-world multicenter study
Presenter: Mengye He
Session: Poster session 07
2171P - Incidence of adverse events in patients treated with a combination of immune checkpoint blockers and chemotherapy: A real life cohort
Presenter: Layal Rached
Session: Poster session 07
2172P - Development and evaluation of the usefulness of an immune-related adverse events interview application
Presenter: AKIKO YANO
Session: Poster session 07